These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35680449)

  • 21. [Sarcoidosis : Organ involvement, diagnosis, current treatment].
    Weidenthaler-Barth B; Steinbrink K; Kümmel A; von Stebut E
    Hautarzt; 2015 Jul; 66(7):549-63. PubMed ID: 26077943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sarcoidosis.
    Llanos O; Hamzeh N
    Med Clin North Am; 2019 May; 103(3):527-534. PubMed ID: 30955519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sarcoidosis: a state of the art review from the Thoracic Society of Australia and New Zealand.
    Ahmadzai H; Huang S; Steinfort C; Markos J; Allen RK; Wakefield D; Wilsher M; Thomas PS
    Med J Aust; 2018 Jun; 208(11):499-504. PubMed ID: 29719195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sarcoidosis as a systemic disease.
    Sehgal VN; Riyaz N; Chatterjee K; Venkatash P; Sharma S
    Clin Dermatol; 2014; 32(3):351-63. PubMed ID: 24767183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laryngeal sarcoidosis: unique location or first manifestation?].
    Lede Barreiro A; Díaz Argüello JJ; Fernández Martínez JA; Martínez Ferreras A
    Acta Otorrinolaringol Esp; 2012; 63(3):230-2. PubMed ID: 21342679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sarcoidosis--a diagnostic and therapeutic problem].
    Wojas-Pelc A; Setkowicz M; Lipko-Godlewska S
    Przegl Lek; 2000; 57(11):659-64. PubMed ID: 11293215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sarcoidosis: is therapy effective?
    Baughman RP; Sharma OP; Lynch JP
    Semin Respir Infect; 1998 Sep; 13(3):255-73. PubMed ID: 9764955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and Tolerance of Anti-Tumor Necrosis Factor α Agents in Cutaneous Sarcoidosis: A French Study of 46 Cases.
    Heidelberger V; Ingen-Housz-Oro S; Marquet A; Mahevas M; Bessis D; Bouillet L; Caux F; Chapelon-Abric C; Debarbieux S; Delaporte E; Duval-Modeste AB; Fain O; Joly P; Marchand-Adam S; Monfort JB; Noël N; Passeron T; Ruivard M; Sarrot-Reynauld F; Verrot D; Bouvry D; Fardet L; Chosidow O; Sève P; Valeyre D
    JAMA Dermatol; 2017 Jul; 153(7):681-685. PubMed ID: 28564695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skin manifestations of sarcoidosis.
    Mañá J; Marcoval J
    Presse Med; 2012 Jun; 41(6 Pt 2):e355-74. PubMed ID: 22579238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.
    Marangoni S; Argentiero V; Tavolato B
    J Neurol; 2006 Apr; 253(4):488-95. PubMed ID: 16283095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac sarcoidosis: diagnosis and management.
    Markatis E; Afthinos A; Antonakis E; Papanikolaou IC
    Rev Cardiovasc Med; 2020 Sep; 21(3):321-338. PubMed ID: 33070538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurological complications of sarcoidosis.
    Stern BJ
    Curr Opin Neurol; 2004 Jun; 17(3):311-6. PubMed ID: 15167067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated renal sarcoidosis: a rare presentation of a rare disease treated with infliximab.
    Ahmed MM; Mubashir E; Dossabhoy NR
    Clin Rheumatol; 2007 Aug; 26(8):1346-9. PubMed ID: 16850114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis.
    Pande A; Culver DA
    Expert Rev Respir Med; 2020 Mar; 14(3):285-298. PubMed ID: 31868547
    [No Abstract]   [Full Text] [Related]  

  • 35. Infliximab therapy in refractory sarcoidosis: a multicenter real-world analysis.
    Sakkat A; Cox G; Khalidi N; Larche M; Beattie K; Renzoni EA; Morar N; Kouranos V; Kolb M; Hambly N
    Respir Res; 2022 Mar; 23(1):54. PubMed ID: 35264154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurosarcoidosis - clinical characteristics, diagnosis and treatment].
    Horyniecki M; Konieczna M; Torbus M; Pierzchała K; Wawrzyńczyk M; Łabuz-Roszak B
    Wiad Lek; 2016; 69(1 Pt 2):92-8. PubMed ID: 27164284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sarcoidosis--an uncommon cause of pancreatic mass].
    Luchansky M; Bergman M; Salman H
    Harefuah; 2004 Jun; 143(6):401-3, 464. PubMed ID: 15524093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preschool sarcoidosis.
    Wisuthsarewong W; Viravan S; Manonukul J
    J Med Assoc Thai; 2000 Nov; 83(11):1415-9. PubMed ID: 11215875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Life-threatening hypercalcemia and acute kidney injury induced by etanercept].
    Tsevi YM; Aydin S; Durez P; Labriola L
    Nephrol Ther; 2018 Nov; 14(6):478-482. PubMed ID: 30401463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of sarcoidosis: grading the evidence.
    James WE; Baughman R
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):677-687. PubMed ID: 29883224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.